Clinical Trial Update: CAPOX and PD-1 Antibody Combined With or Without Radiotherapy for MSS Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating CAPOX with a PD-1 antibody, with or without radiotherapy, for MSS locally advanced rectal cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• PD-1 antibody (PD-1 inhibitor)

Snippet

Sponsor: Fudan University | Conditions: Locally Advanced Rectal Cancer, Neoadjuvant Therapy | Phase 2 | Status: RECRUITING